Literature DB >> 1701784

Immunization with a peptide having both T cell and conformationally restricted B cell epitopes elicits neutralizing antisera against a snake neurotoxin.

M Léonetti1, L Pillet, B Maillère, H Lamthanh, P Frachon, J Couderc, A Ménez.   

Abstract

We have synthesized a free peptide capable of eliciting antibodies that neutralize toxin alpha from Naja nigricollis, a protein that binds specifically to the acetylcholine nicotinic receptor. Of the five tested fragments that encompassed the whole toxin sequence, only fragment 24-41 stimulated T cells from BALB/c mice primed with the whole toxin and conversely, only T cells from mice primed with fragment 24-41 could be stimulated by both the toxin and priming peptide. No other peptides had such properties, indicating that only fragment 24-41 possessed T determinant(s) in BALB/c mice (H-2d haplotype). In agreement with the current view that B cell proliferation requires specific T cell stimulation, only fragment 24-41 elicited an antibody response. However, the antipeptide antisera failed to bind to the native toxin and thereby to neutralize it. Instead, it recognized an unfolded form of the toxin. The peptide 24-41 was then made cyclic. A circular dichroism analysis revealed that, in organic solvent, this peptide had a tendency to adopt a beta-sheet structure, as in the folded toxin, whereas the linear peptide adopted an helical structure. The cyclic peptide not only remained T stimulating but elicited antisera that recognized and neutralized the native toxin. Furthermore, the antisera cross-reacted with several toxin variants. Our data show, therefore, that it is possible to give an appropriate B cell specificity directly to a T cell-stimulating peptide, an approach that may be of value for the design of synthetic vaccines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701784

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  T-helper functions in lines of mice selected for high or low antibody production (Selection III): modulation by anti-CD4+ monoclonal antibody.

Authors:  M H Reis; O M Ibanez; W H Cabrera; O G Ribeiro; D Mouton; M Siqueira; J Couderc
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

2.  Immunoreactivity between a monoclonal lupus autoantibody and the arginine/aspartic acid repeats within the U1-snRNP 70K autoantigen is conformationally restricted.

Authors:  S Pelsue; P F Agris
Journal:  J Protein Chem       Date:  1994-05

Review 3.  Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: problems and prospects.

Authors:  Salvador Eugenio C Caoili
Journal:  J Biomed Biotechnol       Date:  2010-03-30

4.  Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.

Authors:  L T Chin; J Hinkula; M Levi; M Ohlin; B Wahren; C A Borrebaeck
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

5.  Presentation of antigen in immune complexes is boosted by soluble bacterial immunoglobulin binding proteins.

Authors:  M Léonetti; J Galon; R Thai; C Sautès-Fridman; G Moine; A Ménez
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

6.  Development of a Broad-Spectrum Antiserum against Cobra Venoms Using Recombinant Three-Finger Toxins.

Authors:  Bing-Sin Liu; Bo-Rong Jiang; Kai-Chieh Hu; Chien-Hsin Liu; Wen-Chin Hsieh; Min-Han Lin; Wang-Chou Sung
Journal:  Toxins (Basel)       Date:  2021-08-10       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.